Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Esperion Therapeutics, Inc. (ESPR)

« Back to company index

ESPR Chatter Timeline

Stock Ticker for ESPR

Most Active Tweeters for ESPR

UserTweets
@Gupta_Calling 11
@MareaInformativ 8
@1MinuteStock 7
@TickerReport 6
@ThisLincolnian 5

Recent Tweets for ESPR

4thQuarterCap @4thQuarterCap
$ESPR watching for entry again. Data in August then in September ? https://t.co/ComsJYplcm
12:07am
dailypoliticaln @dailypoliticaln
-$1.77 Earnings Per Share Expected for Esperion Therapeutics Inc $ESPR This Quarter https://t.co/4HBHmtsRhb
July 15th 2018, 3:07pm
TickerReport @TickerReport
Esperion Therapeutics Inc $ESPR Expected to Post Earnings of -$1.77 Per Share https://t.co/DWwokd5O2r
July 15th 2018, 3:07pm
WatchlistN @WatchlistN
Zacks: Brokerages Anticipate Esperion Therapeutics Inc $ESPR Will Post Earnings of -$1.77 Per Share https://t.co/UagrjOfWUG
July 15th 2018, 2:07pm
MareaInformativ @MareaInformativ
Esperion Therapeutics Inc $ESPR Expected to Announce Earnings of -$1.77 Per Share https://t.co/aOou9QrQxm
July 15th 2018, 2:07pm
ledgerzette @ledgerzette
Esperion Therapeutics $ESPR Cut to “Market Perform” at Northland Securities https://t.co/2kfn0DE4hE
July 15th 2018, 10:07am
dailypoliticaln @dailypoliticaln
Target N. V. Biotech Acquires 50,000 Shares of Esperion Therapeutics Inc $ESPR Stock https://t.co/kGQmxzya9s
July 15th 2018, 9:07am
TickerReport @TickerReport
Esperion Therapeutics Inc $ESPR Major Shareholder Target N. V. Biotech Acquires 50,000 Shares of Stock https://t.co/r3sI6WDl3X
July 15th 2018, 9:07am
MareaInformativ @MareaInformativ
Esperion Therapeutics Inc $ESPR Major Shareholder Target N. V. Biotech Acquires 50,000 Shares of Stock https://t.co/W8mmVjZBvE
July 15th 2018, 8:07am
dakotafinancial @dakotafinancial
Esperion Therapeutics $ESPR Cut to “Market Perform” at Northland Securities https://t.co/GdBGzzgzTs
July 15th 2018, 7:07am
WeekHerald @WeekHerald
Esperion Therapeutics $ESPR Rating Lowered to Hold at BidaskClub https://t.co/vDkjwv6pC2
July 15th 2018, 6:07am
OlympiaReport @OlympiaReport
Esperion Therapeutics $ESPR Cut to “Hold” at BidaskClub https://t.co/f0KalpTh9h
July 15th 2018, 6:07am
bibeypost_stock @bibeypost_stock
How Many Esperion Therapeutics, Inc. $ESPR's Analysts Are Bearish? - https://t.co/gSjuW2O6Bk
July 15th 2018, 6:07am
reurope_stock @reurope_stock
Are Analysts Bullish about Esperion Therapeutics, Inc. $ESPR after last week? https://t.co/bo9dOXiV7m
July 15th 2018, 6:07am
mmahotstuff1 @mmahotstuff1
Are Analysts Bullish about Esperion Therapeutics, Inc. $ESPR after last week? - https://t.co/BNUTbq33Jn
July 15th 2018, 6:07am
whatsonthorold2 @whatsonthorold2
Can analysts adopt a bullish outlook for Esperion Therapeutics, Inc. $ESPR? - https://t.co/DAOyqx9JIo
July 15th 2018, 6:07am
TheMarketsDaily @TheMarketsDaily
Esperion Therapeutics $ESPR Cut to Sell at Zacks Investment Research https://t.co/lbOet5N4hU
July 15th 2018, 5:07am
ThisLincolnian @ThisLincolnian
BidaskClub Downgrades Esperion Therapeutics $ESPR to Hold https://t.co/X5t2idq2J6
July 15th 2018, 4:07am
WatchlistN @WatchlistN
Esperion Therapeutics $ESPR Cut to Sell at Zacks Investment Research https://t.co/laRPOqnR7k
July 15th 2018, 3:07am
MareaInformativ @MareaInformativ
Esperion Therapeutics $ESPR Downgraded to Hold at BidaskClub https://t.co/dzyCOPiArX
July 14th 2018, 11:07pm
TheBio_Hunter @TheBio_Hunter
What about your kid brother... $GBT just becuase I am not buying the bear argument, $ESPR was a close second, my ki… https://t.co/Y8LLViKtCj
July 14th 2018, 10:07pm
EnterpriseLeade @EnterpriseLeade
Zacks Investment Research Lowers Esperion Therapeutics $ESPR to Sell https://t.co/mWSG0dddv8
July 14th 2018, 8:07pm
ConsumerFeed @ConsumerFeed
Esperion Therapeutics Inc $ESPR Major Shareholder Acquires $2,088,500.00 in Stock https://t.co/fuLt4u6ASi
July 14th 2018, 5:07pm
AmericanBanking @AmericanBanking
Esperion Therapeutics Inc $ESPR Major Shareholder Purchases $2,088,500.00 in Stock https://t.co/WpWTtOYB03 #stocks
July 14th 2018, 4:07pm
ConsumerFeed @ConsumerFeed
Esperion Therapeutics Major Shareholder Target Biotech Buys $2,088,500.00 in $ESPR https://t.co/D8bzI3XgRa
July 14th 2018, 4:07pm
filing_scanner @filing_scanner
$ESPR New Insider Filing On: BIOTECH TARGET N V Transaction Code: P https://t.co/4YRTedWIQg https://t.co/yY8uXLVvcJ
July 14th 2018, 1:07pm
reurope_stock @reurope_stock
$-1.77 EPS Expected for Esperion Therapeutics, Inc. $ESPR https://t.co/UqEU2D59fZ
July 14th 2018, 8:07am
mmahotstuff1 @mmahotstuff1
Esperion Therapeutics, Inc. $ESPR Analysts See $-1.77 EPS - https://t.co/XmSjvHJMBU
July 14th 2018, 8:07am
whatsonthorold2 @whatsonthorold2
Analysts See $-1.77 EPS for Esperion Therapeutics, Inc. $ESPR - https://t.co/oVHNziL17e
July 14th 2018, 8:07am
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $ESPR? The Short Ratio is 7.21% https://t.co/A5AE9594PW
July 14th 2018, 5:07am
1MinuteStock @1MinuteStock
Recommendation #HOLD for $ESPR with UB rating - 2.62 out of 5. https://t.co/MPvNiZHft6
July 14th 2018, 4:07am
financhill @financhill
$ESPR is rated a Sell since July 6, 2018 and is 22% below its median level. https://t.co/K1soOW9Fzr https://t.co/uBYdenzSU9
July 14th 2018, 1:07am
filing_scanner @filing_scanner
$ESPR New Insider Filing On: BIOTECH TARGET N V Transaction Code: P https://t.co/4YRTedWIQg https://t.co/c1Yus2yUNY
July 14th 2018, 12:07am
Gupta_Calling @Gupta_Calling
$ESPR Form 4 Esperion Therapeutics, For: Jul 12 Filed by: BB BIOTECH AG BOUGHT 50K shares. They are… https://t.co/N06BfWCyXH
July 13th 2018, 2:07pm
InsiderAlertsIA @InsiderAlertsIA
$ESPR: New Insider Filing on 10%+ Owner BIOTECH TARGET N V: https://t.co/OWGLDOoG0B
July 13th 2018, 2:07pm
quantarb @quantarb
$ESPR insider has just reported purchase of company stock valued at $2,088,300
July 13th 2018, 12:07pm
ataglieri1 @ataglieri1
Insider alert: Insider BIOTECH TARGET N V of $ESPR bought 50,000 shares @ $2,088,300.00
July 13th 2018, 12:07pm
TickerReport @TickerReport
Esperion Therapeutics $ESPR Stock Rating Lowered by Northland Securities https://t.co/6IJcCyRZHN
July 13th 2018, 4:07am
TheMarketsDaily @TheMarketsDaily
Esperion Therapeutics $ESPR Downgraded by Northland Securities to Market Perform https://t.co/dUB7mFt5Bx
July 12th 2018, 12:07pm
AmericanBanking @AmericanBanking
Recent Investment Analysts’ Ratings Updates for Esperion Therapeutics $ESPR https://t.co/G4Kn3IYhuC #stocks
July 12th 2018, 12:07pm
ThisLincolnian @ThisLincolnian
Recent Investment Analysts’ Ratings Updates for Esperion Therapeutics $ESPR https://t.co/VBFMcRSP9N
July 12th 2018, 12:07pm
MareaInformativ @MareaInformativ
Recent Investment Analysts’ Ratings Updates for Esperion Therapeutics $ESPR https://t.co/QsEYwkh0uu
July 12th 2018, 12:07pm
OlympiaReport @OlympiaReport
Esperion Therapeutics $ESPR Stock Price Down 5.3% https://t.co/guSSZrNiDi
July 12th 2018, 12:07pm
dispatchtribune @dispatchtribune
Esperion Therapeutics $ESPR Shares Down 5.3% https://t.co/xkBQhT0c6g
July 12th 2018, 12:07pm
EnterpriseLeade @EnterpriseLeade
Esperion Therapeutics $ESPR Cut to Hold at BidaskClub https://t.co/apN0IQehFU
July 12th 2018, 6:07am
dispatchtribune @dispatchtribune
Esperion Therapeutics $ESPR Cut to Hold at BidaskClub https://t.co/PlBdRPdYFm
July 12th 2018, 4:07am
ZolmaxNews @ZolmaxNews
Esperion Therapeutics $ESPR Rating Lowered to Sell at Zacks Investment Research https://t.co/4FVk7CNxjP
July 12th 2018, 1:07am
biopadawan @biopadawan
RT @tgtxdough: Cowen $ESPR KOLs well-known to the Street expressed with conviction their lack of concern regarding BA’s safety profile. Upc…
July 11th 2018, 3:07pm
Gupta_Calling @Gupta_Calling
$ESPR CLEAR outcomes study. There were no short term investment conclusions drawn out from this note, the analyst… https://t.co/BKvmT8Auwe
July 11th 2018, 2:07pm
Gupta_Calling @Gupta_Calling
$ESPR No change to the price target of $94.00
July 11th 2018, 2:07pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.